Indeed, soluble Aβ peptide-induced hippocampal synaptic dysfunction, as evidenced by reduced expression of synaptic density markers such as synaptophysin (SYP) and post-synaptic density protein-95 (PSD-95)12,13, has been reported in AD patients and AD mouse models14. Here, DLG4 is linked to Alzheimer disease.